ऑस्ट्रेलिया -
अंग्रेज़ी -
Department of Health (Therapeutic Goods Administration)
urso ursodeoxycholic acid 250mg capsule blister pack
dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: colloidal anhydrous silica; titanium dioxide; maize starch; gelatin; sodium lauryl sulfate; magnesium stearate; purified water - the treatment of chronic cholestatic liver diseases.
बेल्जियम -
अंग्रेज़ी -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
ursodeoxycholic acid amdipharm 250 mg hard caps.
amdipharm ltd. - ursodeoxycholic acid 250 mg - capsule, hard - 250 mg - ursodeoxycholic acid 250 mg - liver therapy, lipotropics; a05aa02 ursodeoxycholic acid
आयरलैंड -
अंग्रेज़ी -
HPRA (Health Products Regulatory Authority)
ursodeoxycholic acid 150 milligram tablets
teva b.v. - ursodeoxycholic acid - tablets - 150 milligram - bile acid preparations
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 300mg tablets
wockhardt uk ltd - ursodeoxycholic acid - oral tablet - 300mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 300mg tablets
alliance healthcare (distribution) ltd - ursodeoxycholic acid - oral tablet - 300mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 300mg tablets
a a h pharmaceuticals ltd - ursodeoxycholic acid - oral tablet - 300mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 250mg capsules
advanz pharma - ursodeoxycholic acid - oral capsule - 250mg
यूनाइटेड किंगडम -
अंग्रेज़ी -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 300mg tablets
de pharmaceuticals - ursodeoxycholic acid - oral tablet - 300mg
इसराइल -
अंग्रेज़ी -
Ministry of Health
ursolit 100
cts chemical industries ltd, israel - ursodeoxycholic acid - tablets - ursodeoxycholic acid 100 mg - ursodeoxycholic acid - ursodeoxycholic acid - dissolution or reductin in size of radiolucent cholesterol in patient with a functioning gallbladder. treatment of chronic liver diseases including primary billiary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia, chronic hepatitis, and alcohol cirrhosis.
इसराइल -
अंग्रेज़ी -
Ministry of Health
ursolit 300
cts chemical industries ltd, israel - ursodeoxycholic acid - tablets - ursodeoxycholic acid 300 mg - ursodeoxycholic acid - ursodeoxycholic acid - dissolution or reduction in size of radiolucent cholesterol gallstones in patients with a functioning gallbladder. treatment of chronic liver diseases including primary biliary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia chronic hepatitis and alcoholic cirrhosis.